Previous Next Accountability Covid-19 has exposed the limits of the pharmaceutical market model Abstract: Remdesivir is the poster child for why we need a new model of drug development for pandemics and neglected diseases that isn't market-based. Publication: STAT Date Published: May 19, 2020 Author(s): Tahir Amin and Rohit Malpani View This Resource